{
  "meta": {
    "title": "9_Drugs_For_Glaucoma",
    "url": "https://brainandscalpel.vercel.app/9-drugs-for-glaucoma-a0999ea1.html",
    "scrapedAt": "2025-11-30T12:34:46.295Z"
  },
  "questions": [
    {
      "text": "You want to prescribe a drug that increases uveo-scleral outflow while treating a patient with open-angle glaucoma. Which of the following drugs would you choose?",
      "choices": [
        {
          "id": 1,
          "text": "Prostaglandin analogues"
        },
        {
          "id": 2,
          "text": "Carbonic anhydrase inhibitors"
        },
        {
          "id": 3,
          "text": "Rho-kinase inhibitors"
        },
        {
          "id": 4,
          "text": "Beta-blockers"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The class of anti-glaucoma drugs which act by <strong>increasing</strong> the<strong> uveo-scleral outflow</strong> are <strong>prostaglandin analogues.</strong></p><hr><h3>Related Pearl: Antiglaucoma drugs: Mechanism of lowering intraocular pressure (IOP) at a glance</h3><p><strong>Drugs that increase trabecular outflow</strong></p>\n<ul>\n<li>Miotics (e.g., pilocarpine)</li>\n<li>Epinephrine, dipivefrine</li>\n<li>Bimatoprost</li>\n<li>Rho-kinase inhibitor (Netarsudil)</li>\n</ul>\n<p><strong>Drugs that increase uveoscleral outflow</strong></p>\n<ul>\n<li>Prostaglandins (latanoprost)</li>\n<li>Epinephrine, dipivefrine</li>\n<li>Brimonidine</li>\n<li>Apraclonidine</li>\n</ul>\n<p><strong>Drugs that decrease aqueous production</strong></p>\n<ul>\n<li>Carbonic anhydrase inhibitors (e.g., acetazolamide, dorzolamide)</li>\n<li>Alpha receptor stimulators in ciliary process (e.g., epinephrine, dipivefrine, clonidine, brimonidine, apraclonidine)</li>\n<li>Beta-blockers</li>\n</ul>\n<p><strong>Hyperosmotic agents</strong> - (e.g., glycerol, mannitol, urea)</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/52d74961d2524b3bb5c22c2677259778x1280x1532.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3466",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following anti-glaucoma agents has no effect on aqueous outflow?",
      "choices": [
        {
          "id": 1,
          "text": "Netarsudil"
        },
        {
          "id": 2,
          "text": "Timolol"
        },
        {
          "id": 3,
          "text": "Brimonidine"
        },
        {
          "id": 4,
          "text": "Latanoprost"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Timolol</strong> is a <strong>non-selective beta-blocker. </strong>Beta-blockers reduce intra-ocular pressure primarily by<strong> reducing aqueous humor</strong> production. Another hypothesis states that by reducing ocular blood flow, there may be a decrease in ultrafiltration responsible for aqueous production. </p>\n<p><strong>Netarsudil</strong> is a rho-kinase inhibitor that acts by increasing trabecular outflow.</p>\n<p><strong>Brimonidine</strong> is an alpha-agonist that has a small effect on increasing both uveoscleral and trabecular outflow. </p>\n<p><strong>Latanoprost</strong> is a prostaglandin PGF2-alpha analog that primarily acts by releasing matrix metalloproteinases, thereby increasing trabecular and uveoscleral outflow.</p><hr><h3>Related Pearl: Antiglaucoma drugs: Mechanism of lowering intraocular pressure (IOP) at a glance</h3><p><strong>Drugs that increase trabecular outflow</strong></p>\n<ul>\n<li>Miotics (e.g., pilocarpine)</li>\n<li>Epinephrine, dipivefrine</li>\n<li>Bimatoprost</li>\n<li>Rho-kinase inhibitor (Netarsudil)</li>\n</ul>\n<p><strong>Drugs that increase uveoscleral outflow</strong></p>\n<ul>\n<li>Prostaglandins (latanoprost)</li>\n<li>Epinephrine, dipivefrine</li>\n<li>Brimonidine</li>\n<li>Apraclonidine</li>\n</ul>\n<p><strong>Drugs that decrease aqueous production</strong></p>\n<ul>\n<li>Carbonic anhydrase inhibitors (e.g., acetazolamide, dorzolamide)</li>\n<li>Alpha receptor stimulators in ciliary process (e.g., epinephrine, dipivefrine, clonidine, brimonidine, apraclonidine)</li>\n<li>Beta-blockers</li>\n</ul>\n<p><strong>Hyperosmotic agents</strong> - (e.g., glycerol, mannitol, urea)</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/52d74961d2524b3bb5c22c2677259778x1280x1532.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4642",
      "difficulty": "medium"
    },
    {
      "text": "Dipevefrine is a prodrug of ______.",
      "choices": [
        {
          "id": 1,
          "text": "Noradrenaline"
        },
        {
          "id": 2,
          "text": "Adrenaline"
        },
        {
          "id": 3,
          "text": "Clonidine"
        },
        {
          "id": 4,
          "text": "Dopamine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Dipivefrine</strong> is a prodrug of <strong>adrenaline</strong> (epinephrine).</p>\n<p>Adrenaline has poor corneal penetration. Dipivefrine penetrates the cornea and is converted into adrenaline by the esterases.</p>\n<p>Adrenaline lowers intraocular pressure by:</p>\n<ul>\n<li>Increasing trabecular outflow -&nbsp;<strong>beta-2</strong> receptor-mediated.</li>\n<li>Increasing both trabecular and uveoscleral outflow, and decreasing aqueous production -&nbsp;<strong>alpha</strong> receptor-mediated.&nbsp;</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3473",
      "difficulty": "medium"
    },
    {
      "text": "What is the primary mechanism of action of topical carbonic anhydrase inhibitors in glaucoma?",
      "choices": [
        {
          "id": 1,
          "text": "Increasing trabecular outflow"
        },
        {
          "id": 2,
          "text": "Increasing uveoscleral outflow"
        },
        {
          "id": 3,
          "text": "Reducing aqueous formation"
        },
        {
          "id": 4,
          "text": "Relaxation of trabecular meshwork"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The primary mechanism of action of topical carbonic anhydrase inhibitors in glaucoma is&nbsp;<strong>reducing</strong> the <strong>aqueous</strong> formation. Topical carbonic anhydrase inhibitors act by inhibiting type II isoenzyme of carbonic anhydrase in ciliary body epithelium. This leads to a reduction in fluid transport and decreases aqueous formation and IOP.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3481",
      "difficulty": "easy"
    },
    {
      "text": "A 40-year old man who is suffering from open-angle glaucoma reads about netarsudil being approved as a novel agent for his condition. What is the mechanism of action of this drug?",
      "choices": [
        {
          "id": 1,
          "text": "Carbonic anhydrase inhibition"
        },
        {
          "id": 2,
          "text": "Phosphodiesterase 5 inhibition"
        },
        {
          "id": 3,
          "text": "Rho kinase inhibition"
        },
        {
          "id": 4,
          "text": "GPCR inhibition"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Netarsudil</strong> is a <strong>rho kinase inhibitor</strong> that acts by&nbsp;relaxing the trabecular meshwork. This increases the outflow of aqueous humor and reduces intraocular pressure.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4640",
      "difficulty": "easy"
    },
    {
      "text": "A patient who was started on treatment for glaucoma comes to the casualty with acute onset breathlessness. On auscultation, bilateral wheeze is heard. Which of the following drugs might have led to this adverse effect?",
      "choices": [
        {
          "id": 1,
          "text": "Timolol"
        },
        {
          "id": 2,
          "text": "Betaxolol"
        },
        {
          "id": 3,
          "text": "Latanaprost"
        },
        {
          "id": 4,
          "text": "Acetazolamide"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario is suggestive of <strong>acute bronchial asthma</strong> which was most likely precipitated by <strong>timolol.</strong></p>\n<p>Timolol is a <strong>non-selective beta-blocker</strong> that reduces&nbsp;intraocular pressure by&nbsp;decreasing aqueous formation.<strong>&nbsp;</strong>It&nbsp;<strong>precipitates bronchial asthma</strong> in susceptible individuals by beta-2 blockade.</p>\n<p><strong>Betaxolol</strong> is a<strong> beta-1 selective blocker</strong> that is used in glaucoma and has a lower propensity to precipitate bronchial asthma.</p>\n<p><strong>Latanoprost</strong> is a prostaglandin (<strong>PGF-2&nbsp;alpha</strong>) <strong>analog</strong> and does not precipitate bronchial asthma.&nbsp;</p>\n<p><strong>Acetazolamide</strong> is a <strong>carbonic anhydrase inhibitor</strong> and does not precipitate bronchial asthma.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3467",
      "difficulty": "medium"
    },
    {
      "text": "A patient with diabetic macular edema developed glaucoma. Which of the following drugs would you consider giving last?",
      "choices": [
        {
          "id": 1,
          "text": "Beta blocker"
        },
        {
          "id": 2,
          "text": "Alpha agonist"
        },
        {
          "id": 3,
          "text": "Pilocarpine"
        },
        {
          "id": 4,
          "text": "Prostaglandin analogues"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Prostaglandin analogs are the last drugs to be considered in this patient since macular edema is one of their side effects.</p>\n<p>Adverse effects of PGF 2alpha analogs are:</p>\n<ul>\n<li>Blurring of vision</li>\n<li><strong>Macular edema</strong> (especially in aphakic patients)</li>\n<li>Eyelash hypertrichosis</li>\n<li>Iris pigmentation (<strong>Heterochromia iridis</strong>)</li>\n<li>Peri-orbital fat depletion</li>\n</ul><hr><h3>Related Pearl: Important adverse effects of anti-glaucoma drugs</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Anti-glaucoma drug</strong></span></td>\n<td><span><strong>The adverse effects</strong></span></td>\n</tr>\n<tr>\n<td><span>Beta-blockers</span></td>\n<td>\n<p><span>Corneal hypoesthesia</span></p>\n<p><span>Systemic side effects</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Sympathomimetics</span></td>\n<td>\n<p><span>Lid retraction</span></p>\n<p><span>CNS depression and apnea in infants and children (&lt;2 years)</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Prostaglandin analogs</span></td>\n<td>\n<p><span>Eyelash hypertrichosis</span></p>\n<p><span>Macular edema</span></p>\n<p><span>Iris pigmentation (Heterochromia iridis)</span></p>\n<p><span>Peri-orbital fat depletion</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Miotics</span></td>\n<td>\n<p><span>Retinal detachment</span></p>\n<p><span>Cataract</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Carbonic anhydrase inhibitors</span></td>\n<td>\n<p><span>Systemic side effects</span></p>\n<p><span>Corneal edema</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7024",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is the most appropriate first-line medical therapy in a patient with open-angle glaucoma?",
      "choices": [
        {
          "id": 1,
          "text": "Beta blockers"
        },
        {
          "id": 2,
          "text": "Miotics"
        },
        {
          "id": 3,
          "text": "PGF 2 alpha analogs"
        },
        {
          "id": 4,
          "text": "Carbonic anhydrase inhibitors"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The most appropriate first-line medical therapy for open-angle glaucoma is&nbsp;<strong>PGF-2 alpha analogs.&nbsp;</strong></p>\n<p>They act by <strong>increasing</strong> the <strong>aqueous outflow.</strong>&nbsp;They&nbsp;have largely replaced beta-blockers and&nbsp;can be considered as first-line agents&nbsp;for open-angle glaucoma because of their following properties:</p>\n<ul>\n<li>Once-daily dosing</li>\n<li>Low incidence of systemic side effects</li>\n<li>Potent IOP-lowering effect</li>\n</ul>\n<p>When the use of PGF-2&nbsp;alpha analogs or beta-blockers is contraindicated, topical carbonic anhydrase inhibitors or alpha-2 agonists are used.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3485",
      "difficulty": "medium"
    },
    {
      "text": "You diagnose a patient with primary open-angle glaucoma and decide to prescribe a PGF2 alpha analog. Which of the following drugs would you not choose?",
      "choices": [
        {
          "id": 1,
          "text": "Bimatoprost"
        },
        {
          "id": 2,
          "text": "Travoprost"
        },
        {
          "id": 3,
          "text": "Dinoprost"
        },
        {
          "id": 4,
          "text": "Tafluprost"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Dinoprost</strong> is a derivative of natural <strong>PGF-2 alpha. </strong>It is indicated in the <strong>termination of pregnancy</strong> and <strong>post-partum hemorrhage</strong> and not for use in glaucoma.<strong>&nbsp;</strong></p>\n<p>PGF2 alpha analogs that are used topically for the treatment of glaucoma are:</p>\n<ul>\n<li>Latanoprost</li>\n<li>Bimatoprost</li>\n<li>Travoprost</li>\n<li>Tafluprost</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3479",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following antiglaucoma medications is unsafe in infants?",
      "choices": [
        {
          "id": 1,
          "text": "Timolol"
        },
        {
          "id": 2,
          "text": "Brimonidine"
        },
        {
          "id": 3,
          "text": "Latanoprost"
        },
        {
          "id": 4,
          "text": "Dorzolamide"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The use of <strong>brimonidine </strong>is<strong> unsafe </strong>in infants<strong>. </strong>It is an<strong> alpha-2 agonist</strong>&nbsp;that&nbsp;can cross the blood-brain barrier. This&nbsp;may result in <strong>CNS depression</strong> and<strong> apnoea</strong> in neonates. Therefore it is contraindicated&nbsp;in children less than 2 years.</p>\n<p>&alpha;<sub>2</sub>&nbsp;agonists, through the activation of G-protein coupled receptor activation, inhibit the activity of adenylate cyclase. This reduces cAMP and hence reduces aqueous humor production by ciliary action.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4915",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following can be administered orally for the treatment of glaucoma?<div class='question-desc-html'><ol>\n<li>Acetazolamide</li>\n<li>Dorzolamide</li>\n<li>Brinzolamide</li>\n<li>Dichlorphenamide</li>\n<li>Methazolamide</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1 and 5"
        },
        {
          "id": 2,
          "text": "1, 2 and 3"
        },
        {
          "id": 3,
          "text": "2, 3 and 4"
        },
        {
          "id": 4,
          "text": "1, 2, 3, 4, 5"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Acetazolamide</strong>&nbsp;and <strong>methazolamide</strong> are carbonic anhydrase inhibitors that can be used&nbsp;<strong>orally</strong>&nbsp;in the treatment of glaucoma.</p>\n<p>Acetazolamide can also be administered intravenously.</p>\n<p><strong>Dorzolamide</strong> and<strong> brinzolamide</strong> are<strong> topical</strong> carbonic anhydrase inhibitors.</p>\n<p><strong>Dichlorphenamide</strong> is a carbonic anhydrase inhibitor approved for the treatment of <strong>familial periodic paralysis.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3480",
      "difficulty": "medium"
    },
    {
      "text": "Intravenous mannitol is used in ____?",
      "choices": [
        {
          "id": 1,
          "text": "Pulmonary edema"
        },
        {
          "id": 2,
          "text": "Congestive cardiac failure"
        },
        {
          "id": 3,
          "text": "Acute kidney injury with anuria"
        },
        {
          "id": 4,
          "text": "Glaucoma"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Intravenous mannitol is used for the treatment of acute attacks of <strong>glaucoma.</strong></p>\n<p>Uses of mannitol are:</p>\n<ul>\n<li>To reduce cerebral edema and intracranial pressure</li>\n<li>Enhancement of urinary excretion of salicylates, barbiturates, bromides, and lithium</li>\n<li>Diagnosis of bronchial hyperreactivity (inhalation)</li>\n<li>Antihemolytic urological irrigation during transurethral procedures</li>\n<li>Treatment of acute attacks of glaucoma.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7468",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following drugs should not be given in a patient prone to developing angle-closure glaucoma?",
      "choices": [
        {
          "id": 1,
          "text": "Pilocarpine"
        },
        {
          "id": 2,
          "text": "Clozapine"
        },
        {
          "id": 3,
          "text": "Rivastigmine"
        },
        {
          "id": 4,
          "text": "Neostigmine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Clozapine</strong> is an atypical antipsychotic having significant <strong>anticholinergic</strong> action.&nbsp;Drugs having significant anticholinergic action should be <strong>avoided</strong> or used with extreme caution in patients prone to developing <strong>acute angle-closure glaucoma</strong>.</p>\n<p>The anticholinergic action results in the <strong>relaxation</strong> of the <strong>sphincter pupillae</strong> muscle. This results in the iris coming in contact with the lens and thereby obstructing the movement of the aqueous from the posterior to the anterior chamber.</p>\n<p>This results in bulging of the iris and further leads to the <strong>obliteration</strong> of the narrow <strong>iridocorneal angle</strong>. This blocks the outflow of aqueous precipitating an <strong>acute attack of glaucoma.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3482",
      "difficulty": "medium"
    },
    {
      "text": "While examining a patient using a corneal esthesiometer, you find that corneal sensations are decreased. Which of the following drugs could have led to this adverse effect?",
      "choices": [
        {
          "id": 1,
          "text": "Beta blockers"
        },
        {
          "id": 2,
          "text": "Carbonic anhydrase inhibitors"
        },
        {
          "id": 3,
          "text": "Cholinomimetics"
        },
        {
          "id": 4,
          "text": "Prostaglandin analogs"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Corneal hypoesthesia</strong> is a side effect of <strong>ocular beta-blockers</strong>.</p>\n<p>For topical use in glaucoma, beta-blockers with no/minimal membrane-stabilizing action are used.&nbsp;This is the reason why propranolol is not formulated for ocular use. It has the highest membrane-stabilizing action and causes maximum corneal hypoesthesia if used.</p><hr><h3>Related Pearl: Important adverse effects of anti-glaucoma drugs</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Anti-glaucoma drug</strong></span></td>\n<td><span><strong>The adverse effects</strong></span></td>\n</tr>\n<tr>\n<td><span>Beta-blockers</span></td>\n<td>\n<p><span>Corneal hypoesthesia</span></p>\n<p><span>Systemic side effects</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Sympathomimetics</span></td>\n<td>\n<p><span>Lid retraction</span></p>\n<p><span>CNS depression and apnea in infants and children (&lt;2 years)</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Prostaglandin analogs</span></td>\n<td>\n<p><span>Eyelash hypertrichosis</span></p>\n<p><span>Macular edema</span></p>\n<p><span>Iris pigmentation (Heterochromia iridis)</span></p>\n<p><span>Peri-orbital fat depletion</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Miotics</span></td>\n<td>\n<p><span>Retinal detachment</span></p>\n<p><span>Cataract</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Carbonic anhydrase inhibitors</span></td>\n<td>\n<p><span>Systemic side effects</span></p>\n<p><span>Corneal edema</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3470",
      "difficulty": "medium"
    },
    {
      "text": "A patient presents with severe eye pain to the ophthalmology OPD. On examination, there is circumcorneal congestion and the IOP is 40 mm Hg. Which of the following drugs should not be administered immediately to this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Acetazolamide"
        },
        {
          "id": 2,
          "text": "Timolol"
        },
        {
          "id": 3,
          "text": "Latanoprost"
        },
        {
          "id": 4,
          "text": "Pilocarpine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given scenario is suggestive of <strong>acute angle-closure glaucoma.&nbsp;</strong>Pilocarpine should not be administered immediately in this condition.</p>\n<p>During an acute attack, the elevated pressure in the anterior chamber causes <strong>pressure-induced ischemic paralysis</strong> of the <strong>iris. Pilocarpine</strong> would be <strong>ineffective</strong> in this phase.&nbsp;</p>\n<p>Once the IOP is reduced by other agents and reperfusion is achieved, <strong>pilocarpine</strong> can be used to <strong>overcome</strong> the <strong>pupillary block</strong>.&nbsp;</p>\n<p>Pilocarpine is avoided in conditions like pseudo-exfoliation syndrome, phacomorphic glaucoma, and aqueous misdirection syndrome as it may exacerbate pupillary block in such cases.&nbsp;</p>\n<p>Topical beta-blockers, alpha-2 agonists and prostaglandin analogs can be used to decrease the IOP initially at presentation. Oral or intravenous acetazolamide can also be used.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4639",
      "difficulty": "hard"
    },
    {
      "text": "A patient who is on treatment for glaucoma presented with the following finding during his routine follow-up. Which of the following drugs can cause this adverse effect?",
      "choices": [
        {
          "id": 1,
          "text": "Timolol"
        },
        {
          "id": 2,
          "text": "Latanoprost"
        },
        {
          "id": 3,
          "text": "Brimonidine"
        },
        {
          "id": 4,
          "text": "Apraclonidine"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The patient has presented with<strong> lid retraction</strong>&nbsp;which is most likely caused by the use of&nbsp;<strong>apraclonidine.</strong> It is a congener of clonidine that has primary &alpha;<sub>2</sub> agonist action and a subsidiary &alpha;<sub>1</sub> agonist action.</p>\n<p>Adverse effects like mydriasis and lid retraction are common with apraclonidine.</p>\n<p>Brimonidine is also a congener of clonidine with more &alpha;<sub>2</sub> selectivity. Mydriasis and lid retraction are uncommon with this agent.</p>\n<p>Timolol and latanoprost do not cause lid retraction.</p><hr><h3>Related Pearl: Important adverse effects of anti-glaucoma drugs</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Anti-glaucoma drug</strong></span></td>\n<td><span><strong>The adverse effects</strong></span></td>\n</tr>\n<tr>\n<td><span>Beta-blockers</span></td>\n<td>\n<p><span>Corneal hypoesthesia</span></p>\n<p><span>Systemic side effects</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Sympathomimetics</span></td>\n<td>\n<p><span>Lid retraction</span></p>\n<p><span>CNS depression and apnea in infants and children (&lt;2 years)</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Prostaglandin analogs</span></td>\n<td>\n<p><span>Eyelash hypertrichosis</span></p>\n<p><span>Macular edema</span></p>\n<p><span>Iris pigmentation (Heterochromia iridis)</span></p>\n<p><span>Peri-orbital fat depletion</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Miotics</span></td>\n<td>\n<p><span>Retinal detachment</span></p>\n<p><span>Cataract</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Carbonic anhydrase inhibitors</span></td>\n<td>\n<p><span>Systemic side effects</span></p>\n<p><span>Corneal edema</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/cf4ce6ea1d734980be8dc6aca59a7202.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3472",
      "difficulty": "medium"
    },
    {
      "text": "The ophthalmologic examination of a patient who is on anti-glaucoma drugs shows the following finding. Identify the drug that might have resulted in this adverse effect.",
      "choices": [
        {
          "id": 1,
          "text": "Carbonic anhydrase inhibitors"
        },
        {
          "id": 2,
          "text": "Anticholinesterase agents"
        },
        {
          "id": 3,
          "text": "Muscaranic antagonists"
        },
        {
          "id": 4,
          "text": "Sympathomimetic agents"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The ophthalmological examination shows a pearly white opacity of the lens suggestive of <strong>cataract.</strong> Anticholinesterase agents like <strong>echothiophate </strong>and cholinergic agonists like<strong> pilocarpine </strong>are known to be associated with cataract formation.</p><hr><h3>Related Pearl: Important adverse effects of anti-glaucoma drugs</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Anti-glaucoma drug</strong></span></td>\n<td><span><strong>The adverse effects</strong></span></td>\n</tr>\n<tr>\n<td><span>Beta-blockers</span></td>\n<td>\n<p><span>Corneal hypoesthesia</span></p>\n<p><span>Systemic side effects</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Sympathomimetics</span></td>\n<td>\n<p><span>Lid retraction</span></p>\n<p><span>CNS depression and apnea in infants and children (&lt;2 years)</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Prostaglandin analogs</span></td>\n<td>\n<p><span>Eyelash hypertrichosis</span></p>\n<p><span>Macular edema</span></p>\n<p><span>Iris pigmentation (Heterochromia iridis)</span></p>\n<p><span>Peri-orbital fat depletion</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Miotics</span></td>\n<td>\n<p><span>Retinal detachment</span></p>\n<p><span>Cataract</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Carbonic anhydrase inhibitors</span></td>\n<td>\n<p><span>Systemic side effects</span></p>\n<p><span>Corneal edema</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/87b025569bd448c6bd82e3b3275f638b.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3483",
      "difficulty": "medium"
    },
    {
      "text": "A patient who is on anti-glaucoma therapy presents with corneal findings as shown in the image below. This finding is most commonly observed with which of the following drugs?",
      "choices": [
        {
          "id": 1,
          "text": "Timolol"
        },
        {
          "id": 2,
          "text": "Apraclonidine"
        },
        {
          "id": 3,
          "text": "Netarsudil"
        },
        {
          "id": 4,
          "text": "Brimonidine"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The bilateral <strong>whorl-like</strong>&nbsp;pattern of cream-colored lines on the cornea seen in the image is called<strong> cornea verticillata </strong>or<strong> vortex keratopathy. </strong>It&nbsp;is observed with the use of <strong>netarsudil</strong>. It is usually mild and reversible and not associated with any significant visual abnormalities.&nbsp;</p>\n<p>Netarsudil is approved for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension.</p>\n<p><strong>Other causes of corneal verticillata are</strong>:&nbsp;</p>\n<ul>\n<li>Fabry&rsquo;s disease</li>\n<li>Amiodarone</li>\n<li>Chloroquine</li>\n<li>Hydroxychloroquine</li>\n<li>Indomethacin</li>\n<li>Phenothiazines.</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/9551b059503648af8f454cfbc8127fe6.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4641",
      "difficulty": "medium"
    },
    {
      "text": "A patient on treatment for glaucoma presented with complaints of floaters and flashing lights. He complains of seeing a dark grey curtain move across his field of vision. Which of the following can lead to this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Beta-blockers"
        },
        {
          "id": 2,
          "text": "Prostaglandin analogs"
        },
        {
          "id": 3,
          "text": "Cholinergic agonists"
        },
        {
          "id": 4,
          "text": "Muscarinic antagonists"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given scenario is suggestive of <strong>retinal detachment. </strong>It<strong>&nbsp;</strong>is associated with the use of<strong> miotics</strong> i.e., both <strong>cholinergic agonists</strong> and <strong>anticholinesterase</strong> agents.</p>\n<p>Miotics produce ciliary body contraction which can lead to altered forces at the vitreous base resulting in retinal tears.&nbsp;Hence, they are to be used with extreme caution in patients who are at risk of developing retinal detachment.</p><hr><h3>Related Pearl: Important adverse effects of anti-glaucoma drugs</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Anti-glaucoma drug</strong></span></td>\n<td><span><strong>The adverse effects</strong></span></td>\n</tr>\n<tr>\n<td><span>Beta-blockers</span></td>\n<td>\n<p><span>Corneal hypoesthesia</span></p>\n<p><span>Systemic side effects</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Sympathomimetics</span></td>\n<td>\n<p><span>Lid retraction</span></p>\n<p><span>CNS depression and apnea in infants and children (&lt;2 years)</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Prostaglandin analogs</span></td>\n<td>\n<p><span>Eyelash hypertrichosis</span></p>\n<p><span>Macular edema</span></p>\n<p><span>Iris pigmentation (Heterochromia iridis)</span></p>\n<p><span>Peri-orbital fat depletion</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Miotics</span></td>\n<td>\n<p><span>Retinal detachment</span></p>\n<p><span>Cataract</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Carbonic anhydrase inhibitors</span></td>\n<td>\n<p><span>Systemic side effects</span></p>\n<p><span>Corneal edema</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3484",
      "difficulty": "medium"
    },
    {
      "text": "Your friend who is on treatment for glaucoma tells you that she feels her eyes look prettier than before. On examination, you notice increased iris pigmentation and eyelash hypertrichosis. Which of the following drugs is associated with this effect?",
      "choices": [
        {
          "id": 1,
          "text": "Pilocarpine"
        },
        {
          "id": 2,
          "text": "Acetazolamide"
        },
        {
          "id": 3,
          "text": "Brimonidine"
        },
        {
          "id": 4,
          "text": "Bimatoprost"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Bimatoprost</strong> is a PGF-2 alpha analog. PGF-2 alpha analogs are associated with <strong>eyelash hypertrichosis</strong>&nbsp;and&nbsp;<strong>iris hyperpigmentation</strong>.</p>\n<p>Bimatoprost is approved for topical application in the treatment of eyelash hypotrichosis.</p><hr><h3>Related Pearl: Important adverse effects of anti-glaucoma drugs</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Anti-glaucoma drug</strong></span></td>\n<td><span><strong>The adverse effects</strong></span></td>\n</tr>\n<tr>\n<td><span>Beta-blockers</span></td>\n<td>\n<p><span>Corneal hypoesthesia</span></p>\n<p><span>Systemic side effects</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Sympathomimetics</span></td>\n<td>\n<p><span>Lid retraction</span></p>\n<p><span>CNS depression and apnea in infants and children (&lt;2 years)</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Prostaglandin analogs</span></td>\n<td>\n<p><span>Eyelash hypertrichosis</span></p>\n<p><span>Macular edema</span></p>\n<p><span>Iris pigmentation (Heterochromia iridis)</span></p>\n<p><span>Peri-orbital fat depletion</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Miotics</span></td>\n<td>\n<p><span>Retinal detachment</span></p>\n<p><span>Cataract</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Carbonic anhydrase inhibitors</span></td>\n<td>\n<p><span>Systemic side effects</span></p>\n<p><span>Corneal edema</span></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3476",
      "difficulty": "easy"
    },
    {
      "text": "What is the most probable diagnosis in a patient with a dilated pupil not responsive to 1% pilocarpine?",
      "choices": [
        {
          "id": 1,
          "text": "Diabetic 3rd nerve palsy"
        },
        {
          "id": 2,
          "text": "Adie’s tonic pupil"
        },
        {
          "id": 3,
          "text": "Uncal herniation"
        },
        {
          "id": 4,
          "text": "Pharmacological block"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The most appropriate answer would be a <strong>pharmacological block</strong>. <strong>Antimuscarinic</strong> will <strong>occupy</strong> the <strong>receptors</strong> and results in non-responsiveness to pilocarpine.</p>\n<p>In <strong>diabetic third nerve palsy</strong>, the dilated pupil is due to the loss of innervation to constrictor pupillae. <strong>Muscarinic receptors</strong> on constrictor pupillae will be <strong>intact</strong> resulting in miosis by pilocarpine.</p>\n<p>In <strong>Adie's tonic pupil</strong>, there is <strong>denervation hypersensitivity</strong>. Pupil responds to even lower concentrations of pilocarpine.</p>\n<p><strong>Uncal herniation</strong> causes pressure on the&nbsp;third nerve leading to ipsilateral mydriasis. But <strong>muscarinic receptors</strong> are <strong>intact</strong> and thus the pupil responds to pilocarpine.&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3486",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following cannot be used to decrease intraocular pressure in glaucoma?",
      "choices": [
        {
          "id": 1,
          "text": "Dexamethasone"
        },
        {
          "id": 2,
          "text": "Acetazolamide"
        },
        {
          "id": 3,
          "text": "Apraclonidine"
        },
        {
          "id": 4,
          "text": "Mannitol"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Dexamethasone</strong> is a long-acting glucocorticoid and is not used to decrease the intraocular pressure in glaucoma.</p>\n<p>Acetazolamide, apraclonidine, and mannitol are used in lowering intraocular pressure in glaucoma.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0136",
      "difficulty": "easy"
    }
  ]
}